Brief: MEDINET signs license contract for NeoCart with Histogenics

MEDINET

21/12/2017 06:49

Dec 21 (Reuters) - MEDINET Co Ltd  2370.T  : 
       
    * Says it entered into a license contract for development 
and sale 
of autologous cultured chondrocyte named NeoCart, with 
Histogenics Corp  HSGX.O   
 
     
    Source text in Japanese: https://goo.gl/uXxaAw 
    Further company coverage: HSGX.O  2370.T  
 
 (Beijing Headline News) 
 ((Beijing.HeadlineNews@thomsonreuters.com; +86 62674724; 
Reuters Messaging: Cheng.Li@thomsonreuters.com@reuters.net))